Literature DB >> 21783367

Radiation-induced moyamoya disease after childhood astrocytoma.

Ben Manion1, Wen-Shan Sung.   

Abstract

Adjunctive radiation treatment of childhood intracranial neoplasms of grade II or higher creates a risk of subsequent vasculopathy. A 28-year-old male presented with a Glasgow Coma Scale 12 after acute collapse and hemiparesis with an intraparenchymal haematoma. Emergent craniotomy, histopathology and subsequent imaging confirmed the cause as radiation-induced moyamoya disease, subsequent to treatment for a grade 2 astrocytoma 24 years previously. He had been lost to follow-up after normal serial imaging performed up to 10 years after his initial diagnosis. Long term surveillance imaging may be of benefit in identifying treatable vascular anomalies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21783367     DOI: 10.1016/j.jocn.2011.01.032

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

Review 1.  Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors.

Authors:  Abhishek Bavle; Anand Srinivasan; Farooq Choudhry; Michael Anderson; Michael Confer; Hilarie Simpson; Theresa Gavula; J Spencer Thompson; Shari Clifton; Naina L Gross; Rene McNall-Knapp
Journal:  Neurooncol Pract       Date:  2020-09-28

Review 2.  Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome.

Authors:  Tariq A Hammad; Rula A Hajj-Ali
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.967

3.  Incidence and long-term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan.

Authors:  Yuan-Hung Wu; Feng-Chi Chang; Muh-Lii Liang; Hsin-Hung Chen; Tai-Tong Wong; Sang-Hue Yen; Yi-Wei Chen
Journal:  Cancer Med       Date:  2016-06-05       Impact factor: 4.452

Review 4.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.